title: Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.
abstract: Invasive ductal carcinomas (IDCs) and invasive lobular carcinomas (ILCs) are the two major pathological types of breast cancer. Epidemiological and histoclinical data suggest biological differences, but little is known about the molecular alterations involved in ILCs. We undertook a comparative large-scale study by both array-compared genomic hybridization and cDNA microarray of a set of 50 breast tumors (21 classic ILCs and 29 IDCs) selected on homogeneous histoclinical criteria. Results were validated on independent tumor sets, as well as by quantitative RT-PCR. ILCs and IDCs presented differences at both the genomic and expression levels with ILCs being less rearranged and heterogeneous than IDCs. Supervised analysis defined a 75-BACs signature discriminating accurately ILCs from IDCs. Expression profiles identified two subgroups of ILCs: typical ILCs ( approximately 50%), which were homogeneous and displayed a normal-like molecular pattern, and atypical ILCs, more heterogeneous with features intermediate between ILCs and IDCs. Supervised analysis identified a 75-gene expression signature that discriminated ILCs from IDCs, with many genes involved in cell adhesion, motility, apoptosis, protein folding, extracellular matrix and protein phosphorylation. Although ILCs and IDCs share common alterations, our data show that ILCs and IDCs could be distinguished on the basis of their genomic and expression profiles suggesting that they evolve along distinct genetic pathways.
authors.affiliation: INSERM UMR891, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Marseille, France.
authors.forename: F
authors.initials: F
authors.lastname: Bertucci
authors.forename: B
authors.initials: B
authors.lastname: Orsetti
authors.forename: V
authors.initials: V
authors.lastname: Nègre
authors.forename: P
authors.initials: P
authors.lastname: Finetti
authors.forename: C
authors.initials: C
authors.lastname: Rougé
authors.forename: J-C
authors.initials: JC
authors.lastname: Ahomadegbe
authors.forename: F
authors.initials: F
authors.lastname: Bibeau
authors.forename: M-C
authors.initials: MC
authors.lastname: Mathieu
authors.forename: I
authors.initials: I
authors.lastname: Treilleux
authors.forename: J
authors.initials: J
authors.lastname: Jacquemier
authors.forename: L
authors.initials: L
authors.lastname: Ursule
authors.forename: A
authors.initials: A
authors.lastname: Martinec
authors.forename: Q
authors.initials: Q
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: Bénard
authors.forename: A
authors.initials: A
authors.lastname: Puisieux
authors.forename: D
authors.initials: D
authors.lastname: Birnbaum
authors.forename: C
authors.initials: C
authors.lastname: Theillet
mesh_terms: D015703:Antigens, CD; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D015820:Cadherins / Q000235:genetics / Q000378:metabolism; D018270:Carcinoma, Ductal, Breast / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D018275:Carcinoma, Lobular / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D022202:Chromosomes, Artificial, Bacterial; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009154:Mutation / Q000235:genetics; D009693:Nucleic Acid Hybridization; D020411:Oligonucleotide Array Sequence Analysis; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
chemical_list: D015703:Antigens, CD; C513384:CDH1 protein, human; D015820:Cadherins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53